Urology · Cary, NC
NPI
1811965825
Since 2006
Specialty
Urology
Code 208800000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
110 Kildaire Park Dr Ste 500
Cary, NC, 27518
Phone (919) 467-3203
Groups this clinician bills Medicare through
Medicare paid, 2024
$209K
6,020 services
Medicare patients, 2024
668
Average age 75
Drug cost, 2024
$2.2M
3,427 prescriptions
Company payments, 2025
$2,343
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin P Khoudary was code 99214 (office e&m - established), 1,214 times for 593 patients. In total Kevin P Khoudary billed 6,020 services in 94 codes, and Medicare paid $209K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,214 | 593 | $86.77 | $105K |
| 81003 Clinical Chemistry | Office | 751 | 436 | $2.19 | $1,642 |
| J1071 Injection, testosterone cypionate, 1 mg | Office | 690 | 13 | $0.01 | $5.53 |
| 82570 Clinical Chemistry | Office | 631 | 356 | $5.04 | $3,183 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 361 | 253 | $12.87 | $4,647 |
| 51798 Ultrasound - Nonspecific | Office | 198 | 146 | $7.75 | $1,535 |
| 96372 Injection Administration | Office | 122 | 30 | $10.53 | $1,285 |
| 52000 Cystourethroscopy | Office | 107 | 74 | $170.89 | $18K |
| 99204 Office E&M - New | Office | 85 | 85 | $117.86 | $10K |
| 99211 Office E&M - Established | Office | 50 | 24 | $17.77 | $888 |
| 74018 Standard X-ray | Office | 42 | 34 | $14.47 | $608 |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 31 | 16 | $1.83 | $56.86 |
| 74176 CT/CTA - Abdomen and Pelvis | Office | 22 | 20 | $70.95 | $1,561 |
| 51702 Other Organ Systems | Office | 22 | 12 | $47.80 | $1,052 |
| 76872 Ultrasound - Nonspecific | Facility | 15 | 15 | $24.63 | $369 |
By year: 2022 $282K for 10,236 services; 2023 $240K for 7,127 services; 2024 $209K for 6,020 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 751 | 436 | $2.19 | $1,642 |
| 82570 Clinical Chemistry | 631 | 356 | $5.04 | $3,183 |
| 36415 Venipuncture Blood Collection | 13 | 12 | $8.65 | $112 |
Medicare prescription drug claims, 2024
In 2024, the drug Kevin P Khoudary prescribed most often to Medicare patients was Tamsulosin Hcl, with 979 prescriptions and refills. In total Kevin P Khoudary wrote 3,427 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 979 | 2,249 | 321 | $15K |
| Levofloxacin Generic | 217 | 217 | 173 | $1,082 |
| Finasteride Generic | 214 | 611 | 75 | $2,509 |
| Solifenacin Succinate Generic | 213 | 372 | 71 | $7,581 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 203 | 278 | 94 | $13K |
| Gemtesa Vibegron | 203 | 301 | 57 | $143K |
| Xtandi Enzalutamide | 115 | 115 | 13 | $1.7M |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 109 | 155 | 68 | $1,387 |
| Cephalexin Generic | 103 | 134 | 61 | $2,207 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 96 | 96 | 85 | $602 |
| Myrbetriq Mirabegron | 87 | 144 | 27 | $67K |
| Ciprofloxacin Hcl Generic | 78 | 98 | 61 | $809 |
| Silodosin Generic | 67 | 138 | 22 | $9,143 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 58 | 158 | 23 | $1,852 |
| Testosterone Cypionate Generic | 58 | 74 | 27 | $2,938 |
Brand drugs: - claims; generic drugs: 2,913 claims; opioid claims: 106.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin P Khoudary $2,343 ($2,343 in general payments such as food, travel and fees) from 24 companies. The largest payer was Dendreon Pharmaceuticals LLC with $718.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 14 | $718 |
| Janssen Biotech, Inc. JNJ | 4 | $333 |
| Boston Scientific Corporation BSX | 9 | $309 |
| Abbvie Inc. ABBV | 9 | $177 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $116 |
| Endo USA, Inc. | 5 | $111 |
| Ferring Pharmaceuticals Inc. | 3 | $64.13 |
| Verity Pharmaceuticals Inc. | 3 | $55.91 |
| Merck Sharp & Dohme LLC MRK | 2 | $50.79 |
| Pfizer Inc. PFE | 2 | $48.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.